Marvell’s presentation provides a strong indication that the company is successfully executing its AI-focused strategy. The dramatic growth in data center revenue suggests that Marvell is capitalizing ...

We're living in the era of Big Data. We know more about ourselves—our spending patterns, our TV-watching habits, our Web searches, our education levels—than ever before. For marketers, all that ...

A score test for the null hypothesis of proportional hazards against rank-regression alternatives is proposed as a complement to the logrank test for comparing censored survival curves. The test ...

New non-human primate (NHP) data for VLTR-559, a long-acting anti-VEGF therapy that could reduce the dosing frequency for the treatment of wet age-related macular degeneration (AMD) to twice-yearly, ...

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, and Biogen Inc. (Nasdaq: BIIB), today ...

LONDON and CAMBRIDGE, Mass., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics’ or ‘the Company’), a leading clinical-stage biotechnology company with a ...

In November, IBM and AMD declared plans to pioneer the next generation of computing engineering based on quantum computers matched ...

This study analyzes the ways 100 community-residing men and women aged 45 to 64 coped with the stressful events of daily living during one year. Lazarus's cognitive-phenomenological analysis of ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...